Literature DB >> 24680246

Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy.

Gianluca Campo1, Silvia Punzetti2, Michele Malagù2, Roberto Ferrari3, Marco Valgimigli4.   

Abstract

Entities:  

Keywords:  Drug eluting stent; In-stent restenosis; Percutaneous coronary intervention; Target lesion failure

Mesh：

Year:  2014        PMID： 24680246     DOI： 10.1016/j.ijcard.2014.03.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28

2.  Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.

Authors:  Leos Pleva; Pavel Kukla; Jana Zapletalova; Ota Hlinomaz
Journal:  BMC Cardiovasc Disord       Date:  2017-06-26       Impact factor: 2.298

3.  Associations of anthropometric adiposity indexes with hypertension risk: A systematic review and meta-analysis including PURE-China.

Authors:  Guijuan Deng; Lu Yin; Weida Liu; Xiaoyun Liu; Quanyong Xiang; Zhenzhen Qian; Juntao Ma; Hui Chen; Yang Wang; Bo Hu; Wei Li; Yu Jiang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

4.  Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials.

Authors:  Jin-Zan Cai; Yong-Xiang Zhu; Xin-Yu Wang; Christos V Bourantas; Javaid Iqbal; Hao Zhu; Paul Cummins; Sheng-Jie Dong; Anthony Mathur; Yao-Jun Zhang
Journal:  BMJ Open       Date:  2018-02-22       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.